SCHEMBL879125

SCHEMBL879125

CC(C)(C)C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17589829 0.74
SCHEMBL13450378 0.70
SCHEMBL21099780 0.70
SCHEMBL17552434 0.70
SCHEMBL13008117 0.70
SCHEMBL6914277 0.67
SCHEMBL19034096 0.65
SCHEMBL22749124 0.63
SCHEMBL22536 0.59
SCHEMBL5819577 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112341476-A High-enantioselectivity 7-thia-2-azaspiro [4.5] decane compound and synthesis method thereof 郑州大学 2021-02-09 CN claimed
WO-2005019177-A1 AMINOPIPERIDINE AMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO claimed
CN-117865941-B Substituted piperidine compounds, process for their preparation and their use 上海方予健康医药科技有限公司 2024-06-28 CN disclosed
CN-117865941-A Substituted piperidine compounds, process for their preparation and their use 上海方予健康医药科技有限公司 2024-04-12 CN disclosed
CN-117813302-A Substituted tetrahydrofuran-2-carboxamides as sodium channel modulators 沃泰克斯药物股份有限公司 2024-04-02 CN disclosed
US-20230234954-A1 COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF TYK MEDICINES, INC. (CN) 2023-07-27 US disclosed
US-20230234954-A1 COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF TYK MEDICINES, INC. (CN) 2023-07-27 US disclosed
US-20230165134-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 US disclosed
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2022-05-10 US disclosed
EP-3515900-B1 COMPOUNDS COMPRISING TWO OR MORE EXOVINYLENE CYCLIC-CARBONATE UNITS BASF SE (DE) 2021-08-11 EP disclosed
EP-3818097-A1 ADHESIVE METHOD USING TWO-COMPONENT ADHESIVES BASED ON COMPOUNDS HAVING CYCLOTHIOCARBONATE UNITS BASF SE (DE) 2021-05-12 EP disclosed
EP-0543880-B1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDINES VIA 1-AZA-1,3-BUTADIENES AND THE 1-AZA-1,3-BUTADIENE INTERMEDIATES DSM NV (NL) 1995-04-19 EP disclosed
EP-0254578-B1 ANTIBIOTIC INTERMEDIATES ELI LILLY AND COMPANY (US) 1993-09-08 EP disclosed
EP-0543880-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDINES VIA 1-AZA-1,3-BUTADIENES AND THE 1-AZA-1,3-BUTADIENE INTERMEDIATES. DSM NV (NL) 1993-06-02 EP disclosed
WO-1993007751-A1 FUNGICIDES FOR THE CONTROL OF TAKE-ALL DISEASE OF PLANTS MONSANTO COMPANY (US) 1993-04-29 WO disclosed
EP-0538231-A1 Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1993-04-21 EP disclosed
WO-1992002505-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDINES VIA 1-AZA-1,3-BUTADIENES AND THE 1-AZA-1,3-BUTADIENE INTERMEDIATES DSM N.V. (NL) 1992-02-20 WO disclosed
US-4772694-A Chiral 3-(1,2,5-trisubstituted imidazolidinone) azetidinone antibiotic intermediates ELI LILLY AND COMPANY (US) 1988-09-20 US disclosed
EP-0254578-A1 Antibiotic intermediates ELI LILLY AND COMPANY (US) 1988-01-27 EP disclosed
US-4001324-A PROCESS FOR PRODUCING N-MONOSUBSTITUTED FORMAMIDES BAYER AKTIENGESELLSCHAFT (DT) 1977-01-04 US disclosed